Alternative NSN: 6505-01-252-0802 |
Item Name: Clorazepate Dipotassium Tablets |
NIIN: 012520802 |
NCB Code: USA (01) |
Manufacturers: Abbott Laboratories Inc, Actavis Inc, Danbury Pharmacal Inc, Mylan Pharmaceuticals Inc, Rugby Group Inc, Schein Henry Inc, Taro Pharmaceuticals Usa Inc, Warner Lambert Ltd |
Are you looking for NSN 6505-01-252-0802 - Clorazepate Dipotassium Tablets parts? We can help! Simply complete the RFQ form given below to get started. The National Stock Number (NSN) is a 13-digit serial number assigned by the US Defense Logistics Agency (DLA) to items that are procured, stocked, and issued through the federal supply system. Parts under NSN 6505-01-252-0802 is 4389-53, NDC00047-0451-30, NDC00074-4389-53, NDC00228-3067-50, NDC00364-2201-05 from manufacturer Abbott Laboratories Inc, Warner Lambert Ltd, Actavis Inc, Schein Henry Inc, Mylan Pharmaceuticals Inc. Use our optimized search engine to find your required part—then submit an instant RFQ for a quick, competitive quote. Here at Aviation Orbit, we make your purchasing process as simple and efficient as possible.
Part No | Manufacturer | Item Name | QTY | RFQ |
---|---|---|---|---|
4389-53 | Abbott Laboratories Inc | clorazepate dipotassium tablets | Avl | RFQ |
NDC00047-0451-30 | Warner Lambert Ltd | clorazepate dipotassium tablets | Avl | RFQ |
NDC00074-4389-53 | Abbott Laboratories Inc | clorazepate dipotassium tablets | Avl | RFQ |
NDC00228-3067-50 | Actavis Inc | clorazepate dipotassium tablets | Avl | RFQ |
NDC00364-2201-05 | Schein Henry Inc | clorazepate dipotassium tablets | Avl | RFQ |
NDC00378-0030-05 | Mylan Pharmaceuticals Inc | clorazepate dipotassium tablets | Avl | RFQ |
NDC00536-4940-05 | Rugby Group Inc | clorazepate dipotassium tablets | Avl | RFQ |
NDC00591-0363-05 | Danbury Pharmacal Inc | clorazepate dipotassium tablets | Avl | RFQ |
NDC51672-4042-02 | Taro Pharmaceuticals Usa Inc | clorazepate dipotassium tablets | Avl | RFQ |
MRC | Criteria | Characteristic |
---|---|---|
AJCN | PROTECTIVE STORAGE FEATURE | SECURITY STORAGE |
AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 3.750 MILLIGRAMS CLORAZEPATE DIPOTASSIUM ACTIVE INGREDIENT |
CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 500.000 TABLETS |
FEAT | SPECIAL FEATURES | SCHEDULE IV CONTROLLED SUBSTANCE CLASSIFICATION |
CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | CLORAZEPATE DIPOTASSIUM TABLETS 3.75MG 500S BT |
CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
6550-01-678-7204 (6550016787204) |
6550-01-678-6938 (6550016786938) |
6550-01-677-7355 (6550016777355) |
6550-01-677-5960 (6550016775960) |
6550-01-677-5895 (6550016775895) |
6550-01-677-2512 (6550016772512) |
6550-01-675-9034 (6550016759034) |
6550-01-674-7273 (6550016747273) |
6550-01-674-7271 (6550016747271) |
6550-01-671-9301 (6550016719301) |
6550-01-671-9115 (6550016719115) |
6550-01-671-4950 (6550016714950) |
We Hope You Choose Us as Your Low-Price, High-Quality Parts Distributor In the Future.
Request for Quote